Plasmacytoid dendritic cells in SSc showed distinctive peak patterns. SSc patients with higher CXCL4 levels have earlier evidence of PF, significantly faster decline in lung function, and a higher prevalence of PF. This evidence concerns the gene PF4 and systemic sclerosis.